En undersøgelse af Guselkumab versus Risankizumab hos deltagere med moderat til svært aktiv Crohns sygdom (CHARGE)
En fase 3b, multicentrisk, randomiseret, åben-label, aktiv-kontrolleret undersøgelse til sammenligning af effektiviteten og sikkerheden af Guselkumab versus Risankizumab i behandlingen af deltagere med moderat til svært aktiv Crohns sygdom
The purpose of this study is to assess how well guselkumab works when compared to risankizumab in participants with moderately to severely active Crohn's Disease (CD; a long-term condition causing severe inflammation of the intestinal tract).
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Fase
Fase
- Fase 3
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Study Contact
- Telefonnummer: 844-434-4210
- E-mail: Participate-In-This-Study1@its.jnj.com
Studiesteder
-
-
-
Brussels, Belgien, 1200
- Rekruttering
- Cliniques Universitaires Saint Luc
-
Brussels, Belgien, 1070
- Rekruttering
- ULB Erasme Ziekenhuis
-
Genk, Belgien, 3600
- Rekruttering
- Ziekenhuis Oost-Limburg
-
Ghent, Belgien, 9000
- Rekruttering
- Ghent University Hospital
-
Leuven, Belgien, 3000
- Rekruttering
- Universitair Ziekenhuis Leuven
-
Liège, Belgien, 4000
- Rekruttering
- CHU de Liege
-
Roeselare, Belgien, 8800
- Rekruttering
- Algemeen Ziekenhuis Delta
-
-
-
-
Alberta
-
Edmonton, Alberta, Canada, T5R 1W2
- Rekruttering
- Gastroenterology and Internal Medicine Research Institute (GIRI)
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V6Z 2K5
- Rekruttering
- GIRI Gastrointestinal Research Institute
-
-
Ontario
-
Hamilton, Ontario, Canada, L8N1Y2
- Rekruttering
- Charlton Digestive Disease Centre
-
London, Ontario, Canada, N6K 1M6
- Rekruttering
- London Digestive Disease Institute
-
Oshawa, Ontario, Canada, L1J 0C7
- Rekruttering
- Taunton Surgical Centre
-
Toronto, Ontario, Canada, M6A 3B4
- Rekruttering
- Toronto Immune and Digestive Health Institute Inc
-
-
Quebec
-
Montreal, Quebec, Canada, H3H1E3
- Rekruttering
- Clinique IMD
-
Montreal, Quebec, Canada, H2X 0C1
- Rekruttering
- Centre Hospitalier de l'Universite de Montreal
-
-
-
-
-
Aarhus C, Danmark, 8200
- Rekruttering
- Aarhus University Hospital
-
Esbjerg, Danmark, 6700
- Rekruttering
- Sydvestjysk Sygehus
-
Gistrup, Danmark, 9260
- Rekruttering
- NAU New Aalborg University Hospital
-
Herlev, Danmark, 2730
- Rekruttering
- Herlev Hospital
-
Hilleroed, Danmark, 3400
- Rekruttering
- Nordsjaellands Hospital, Hillerod
-
Hvidovre, Danmark, 2650
- Rekruttering
- Hvidovre Hospital
-
København NV, Danmark, 2400
- Rekruttering
- Bispebjerg Hospital
-
Odense C, Danmark, 5000
- Rekruttering
- Odense UH og Svendberg sygehus
-
-
-
-
-
Greater London, Det Forenede Kongerige, E1 2AJ
- Rekruttering
- Barts Health NHS Trust
-
Greater London, Det Forenede Kongerige, NW10 7NS
- Rekruttering
- London North West University Healthcare NHS Trust
-
Iselworth, Det Forenede Kongerige, TW7 6AF
- Rekruttering
- West Middlesex University Hospital
-
London, Det Forenede Kongerige, NW3 2QG
- Rekruttering
- Royal Free Hospital
-
London, Det Forenede Kongerige, W120HS
- Rekruttering
- Imperial College London
-
London, Det Forenede Kongerige, NW1 2PG
- Rekruttering
- University College London Hospitals Nhs Foundation Trust
-
London, Det Forenede Kongerige, SW10 9NH
- Rekruttering
- Chelsea And Westminster Hospital
-
Norwich, Det Forenede Kongerige, NR4 7UQ
- Rekruttering
- Norfolk and Norwich University Hospital
-
Wolverhampton, Det Forenede Kongerige, WV10 0QP
- Rekruttering
- New Cross Hospital
-
-
-
-
Alabama
-
Dothan, Alabama, Forenede Stater, 36305
- Rekruttering
- Digestive Health Specialists of the Southeast
-
Mobile, Alabama, Forenede Stater, 36608
- Rekruttering
- East View Medical Research
-
-
California
-
Anaheim, California, Forenede Stater, 92805
- Rekruttering
- Clinnova Research
-
Lancaster, California, Forenede Stater, 93534
- Rekruttering
- Gastro Care Institute
-
Los Alamitos, California, Forenede Stater, 90720
- Rekruttering
- United Gastroenterologists
-
Los Angeles, California, Forenede Stater, 90048
- Rekruttering
- TLC Clinical Research Inc
-
Los Angeles, California, Forenede Stater, 90067
- Rekruttering
- GastroIntestinal Bioscience
-
San Diego, California, Forenede Stater, 92123
- Rekruttering
- Medical Associates Research Group, Inc.
-
-
Colorado
-
Colorado Springs, Colorado, Forenede Stater, 80907
- Rekruttering
- Peak Gastroenterology Associates
-
-
Connecticut
-
Hamden, Connecticut, Forenede Stater, 06518
- Rekruttering
- Medical Research Center of Connecticut
-
-
Florida
-
Jacksonville, Florida, Forenede Stater, 32258
- Rekruttering
- Green Leaf Clinical Trials
-
Miami, Florida, Forenede Stater, 33157-6575
- Rekruttering
- Sanchez Clinical Research, Inc
-
Miami, Florida, Forenede Stater, 33186
- Rekruttering
- Biodax Medical Research Trials
-
Naples, Florida, Forenede Stater, 34102
- Rekruttering
- GI Pros Research
-
Orlando, Florida, Forenede Stater, 32806
- Rekruttering
- Orlando Health Digestive Health Institute
-
Tampa, Florida, Forenede Stater, 33609
- Rekruttering
- GCP Clinical Research
-
-
Georgia
-
Atlanta, Georgia, Forenede Stater, 30310
- Rekruttering
- Morehouse School of Medicine
-
Atlanta, Georgia, Forenede Stater, 30342
- Suspenderet
- Atlanta Gastroenterology Associates
-
Macon, Georgia, Forenede Stater, 31201
- Rekruttering
- Gastroenterology Associates of Central GA
-
-
Illinois
-
Northbrook, Illinois, Forenede Stater, 60062
- Rekruttering
- Comprehensive Gastrointestinal Health Libertyville
-
-
Iowa
-
Clive, Iowa, Forenede Stater, 50325
- Rekruttering
- Heartland Medical Research Inc
-
-
Kansas
-
Topeka, Kansas, Forenede Stater, 66606
- Rekruttering
- Cotton-O'Neil Clinical Research Center
-
-
Louisiana
-
Lafayette, Louisiana, Forenede Stater, 70503
- Rekruttering
- Gastroenterology Clinic of Acadiana
-
Shreveport, Louisiana, Forenede Stater, 71103
- Rekruttering
- Louisiana State University Health Sciences Center Shreveport
-
-
Maryland
-
Glen Burnie, Maryland, Forenede Stater, 21061
- Rekruttering
- Woodholme Gastroenterology Associates
-
-
Massachusetts
-
New Bedford, Massachusetts, Forenede Stater, 02740
- Rekruttering
- Lucida Clinical Trials
-
-
Michigan
-
Farmington Hills, Michigan, Forenede Stater, 48334
- Rekruttering
- Michigan Center of Medical Research
-
-
New York
-
Carmel, New York, Forenede Stater, 10512
- Rekruttering
- Westchester Putnam Gastroenterology
-
New York, New York, Forenede Stater, 10028
- Rekruttering
- New York Gastroenterology Associates
-
New York, New York, Forenede Stater, 10075
- Suspenderet
- Lenox Hill Hospital
-
-
North Carolina
-
Chapel Hill, North Carolina, Forenede Stater, 27599 7080
- Rekruttering
- University of North Carolina at Chapel Hill
-
Charlotte, North Carolina, Forenede Stater, 28207
- Rekruttering
- Charlotte Gastroenterology and Hepatology, PLLC
-
-
Ohio
-
Mentor, Ohio, Forenede Stater, 44060
- Rekruttering
- Great Lakes Gastroenterology Research, LLC
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Forenede Stater, 73114
- Rekruttering
- Digestive Disease Specialists Inc
-
-
Pennsylvania
-
Uniontown, Pennsylvania, Forenede Stater, 15401
- Rekruttering
- Frontier Clinical Research
-
-
South Carolina
-
Summerville, South Carolina, Forenede Stater, 29486
- Rekruttering
- Palmetto Primary and Specialty Care Physicians, Charleston
-
-
Texas
-
Carrollton, Texas, Forenede Stater, 75010
- Rekruttering
- DFW Clinical Trials
-
Lubbock, Texas, Forenede Stater, 79424
- Rekruttering
- Lubbock Gastroenterology
-
San Antonio, Texas, Forenede Stater, 78229
- Rekruttering
- Gastroenterology Research of America, LLC
-
San Antonio, Texas, Forenede Stater, 78229
- Rekruttering
- Southern Star Research Institute, LLC
-
Tyler, Texas, Forenede Stater, 75708
- Rekruttering
- The University of Texas Health Science Center at Tyler
-
-
-
-
-
Amiens, Frankrig, 80000
- Rekruttering
- CHU Amiens Picardie
-
Clermont-Ferrand, Frankrig, 63000
- Rekruttering
- Clermont Ferrand University Hospital
-
Marseille, Frankrig, 13015
- Rekruttering
- Aphm - Hopital Nord
-
Nantes, Frankrig, 44000
- Rekruttering
- CHU Nantes - Hotel Dieu
-
Neuilly-sur-Seine, Frankrig, 92200
- Rekruttering
- Clinique Ambroise Pare
-
Nîmes, Frankrig, 30900
- Rekruttering
- CHU Nimes
-
Paris, Frankrig, 75018
- Rekruttering
- APHP - Hopital Bichat - Claude Bernard
-
Paris, Frankrig, 75012
- Rekruttering
- Aphp Hopital Saint Antoine
-
Pierre-Bénite, Frankrig, 69495
- Rekruttering
- Hospices Civils de Lyon CHU Lyon Sud
-
Reims, Frankrig, 51100
- Rekruttering
- CHU de Reims
-
Vandœuvre-lès-Nancy, Frankrig, 54511
- Rekruttering
- Centre Hospitalier Universitaire de Nancy - Hôpital Central
-
Échirolles, Frankrig, 38130
- Rekruttering
- Institut Prive MICI Clinique des Cedres
-
-
-
-
-
Maastricht, Holland, 6229 HX
- Rekruttering
- Maastricht UMC
-
Nijmegen, Holland, 6525 GA
- Rekruttering
- Radboud Umcn
-
Tilburg, Holland, 5022 GC
- Rekruttering
- St. Elisabeth Ziekenhuis
-
-
-
-
-
Bologna, Italien, 40138
- Rekruttering
- A O U Sant Orsola Malpighi
-
Bolzano, Italien, 39100
- Rekruttering
- Azienda Sanitaria dell'Alto Adige - Ospedale di Bolzano
-
Genova, Italien, 16132
- Rekruttering
- Azienda Ospedaliero Universitaria San Martino
-
Milan, Italien, 20132
- Rekruttering
- IRCCS Ospedale San Raffaele
-
Roma, Italien, 00168
- Rekruttering
- Fondazione Policlinico Universitario A Gemelli IRCCS
-
Rozzano, Italien, 20089
- Rekruttering
- Istituto Clinico Humanitas
-
Torino, Italien, 10128
- Rekruttering
- Ospedale Mauriziano Torino
-
-
-
-
-
Changzhou, Kina, 213018
- Rekruttering
- Changzhou No 2 Peoples Hospital
-
Chongqing, Kina, 400014
- Rekruttering
- Chongqing General Hospital
-
Fuzhou, Kina, 350005
- Rekruttering
- The First Affiliated Hospital of Fujian Medical University
-
Guangzhou, Kina, 510655
- Rekruttering
- The Sixth Affiliated Hospital Sun Yat sen University
-
Guangzhou, Kina, 510261
- Rekruttering
- The Second Affiliated Hospital of Guangzhou Medical University
-
Nanjing, Kina, 210009
- Rekruttering
- Zhongda Hospital Southeast University
-
Wuhan, Kina, 430060
- Rekruttering
- Renmin Hospital of Wuhan University
-
-
-
-
-
Bydgoszcz, Polen, 85 229
- Rekruttering
- Centrum Medyczne Medis ManerMed Sp Z O O
-
Krakow, Polen, 30363
- Rekruttering
- Centrum Medyczne Plejady
-
Krakow, Polen, 31-513
- Rekruttering
- Centrum Medyczne Promed
-
Rzeszów, Polen, 35-326
- Rekruttering
- Centrum Medyczne 'Medyk' Sp. z o.o. K.
-
Szczecin, Polen, 71-434
- Rekruttering
- Twoja Przychodnia - Szczecinskie Centrum Medyczne
-
Torun, Polen, 87 100
- Rekruttering
- GASTROMED Kopon Zmudzinski i wspolnicy SP j Specjalistyczne Centrum Gastrologii i Endoskopii
-
Warsaw, Polen, 02-781
- Rekruttering
- Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut Badawczy
-
Warsaw, Polen, 04 501
- Rekruttering
- Medical Network Sp z o o
-
-
-
-
-
Banská Bystrica, Slovakiet, 975 17
- Rekruttering
- FNsP F. D. Roosevelta Banska Bystrica
-
Bratislava, Slovakiet, 811 09
- Rekruttering
- Cliniq s.r.o.
-
Košice, Slovakiet, 040 13
- Rekruttering
- ENDOMED s.r.o
-
Nové Zámky, Slovakiet, 940 34
- Rekruttering
- Fakultna nemocnica s poliklinikou Nove Zamky
-
Prešov, Slovakiet, 080 01
- Rekruttering
- GASTRO I. s.r.o.
-
Prešov, Slovakiet, 080 01
- Rekruttering
- Gastro LM s.r.o.
-
Rimavská Sobota, Slovakiet, 979 12
- Rekruttering
- Vseobecna nemocnica Rimavska Sobota
-
-
-
-
-
Alicante, Spanien, 03010
- Rekruttering
- Hosp. Gral. Univ. Dr. Balmis
-
Barcelona, Spanien, 08036
- Rekruttering
- Hosp. Clinic de Barcelona
-
Ferrol, Spanien, 15405
- Rekruttering
- Hosp. Arquitecto Marcide
-
Gijón, Spanien, 33394
- Rekruttering
- Hosp. de Cabuenes
-
Girona, Spanien, 17007
- Rekruttering
- Hosp. Univ. Dr. Josep Trueta
-
Madrid, Spanien, 28850
- Rekruttering
- Hosp. Univ. de Torrejon
-
Navarra, Spanien, 31008
- Rekruttering
- Hosp. de Navarra
-
Santiago de Compostela, Spanien, 15706
- Rekruttering
- Hosp. Clinico Univ. de Santiago
-
Seville, Spanien, 41009
- Rekruttering
- Hosp. Virgen Macarena
-
-
-
-
-
Linköping, Sverige, 58185
- Rekruttering
- Linkoping University Hospital
-
Mölndal, Sverige, 431 30
- Rekruttering
- Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus
-
Stockholm, Sverige, 171 76
- Rekruttering
- Karolinska Universitetssjukhuset
-
Stockholm, Sverige, 116 30
- Rekruttering
- Ersta sjukhus
-
Stockholm, Sverige, 118 83
- Rekruttering
- Sodersjukhuset
-
Uppsala, Sverige, 751 85
- Rekruttering
- Akademiska Sjukhuset
-
-
-
-
-
Brno, Tjekkiet, 62500
- Rekruttering
- Fakultni nemocnice Brno
-
Brno, Tjekkiet, 636 00
- Rekruttering
- Vojenska nemocnice Brno
-
Hradec Kralova, Tjekkiet, 500 02
- Rekruttering
- Gastroenterologie, s.r.o., Hradec Kralove
-
Hradec Králové, Tjekkiet, 500 12
- Rekruttering
- Hepato-gastroenterologie HK, s.r.o.
-
Ostrava-Poruba, Tjekkiet, 708 00
- Rekruttering
- Fakultni Nemocnice Ostrava
-
Prague, Tjekkiet, 100 00
- Rekruttering
- Fakultni nemocnice Kralovske Vinohrady
-
Prague, Tjekkiet, 14000
- Rekruttering
- Fakultni Thomayerova nemocnice
-
-
-
-
-
Berlin, Tyskland, 10825
- Rekruttering
- GASTRO-Studien
-
Berlin, Tyskland, 12203
- Rekruttering
- Charite Universitaetsmedizin Berlin - Campus Benjamin Franklin (CBF)
-
Erlangen, Tyskland, 91054
- Rekruttering
- Universitatsklinikum Erlangen
-
Grevenbroich, Tyskland, 41515
- Rekruttering
- Praxiszentrum Fur Gastroenterologie und Endoskopie Grevenbroich
-
Jena, Tyskland, 07747
- Rekruttering
- Universitatsklinikum Jena
-
Kiel, Tyskland, 24105
- Rekruttering
- Universitatsklinikum Schleswig Holstein Kiel
-
Ludwigshafen am Rhein, Tyskland, 67067
- Rekruttering
- St. Marien und St. Annastiftskrankenhaus
-
Mannheim, Tyskland, 68167
- Rekruttering
- Universitaetsklinikum Mannheim
-
München, Tyskland, 81675
- Rekruttering
- Klinikum rechts der Isar der TU Munchen
-
-
-
-
-
Budapest, Ungarn, 1088
- Rekruttering
- Semmelweis Egyetem
-
Budapest, Ungarn, 1036
- Rekruttering
- Obudai Egeszsegugyi Centrum Kft
-
Budapest, Ungarn, H-1136
- Rekruttering
- Pannónia Magánorvosi Centrum Kft
-
Budapest, Ungarn, 1082
- Rekruttering
- Semmelweis Egyetem 1
-
Budapest, Ungarn, 1083
- Rekruttering
- Semmelweis Egyetem 2
-
Budapest, Ungarn, 1139
- Rekruttering
- Endomedix
-
Gyöngyös, Ungarn, 3200
- Rekruttering
- Clinexpert Gyongyos Kft
-
Szeged, Ungarn, 6725
- Rekruttering
- Szegedi Tudomanyegyetem
-
-
-
-
-
Graz, Østrig, 8036
- Rekruttering
- LKH-Univ. Klinikum Graz
-
Innsbruck, Østrig, 6020
- Rekruttering
- Medizinische Universitatsklinik Innsbruck
-
Linz, Østrig, 4021
- Rekruttering
- Kepler Universitatsklinikum GmbH
-
Salzburg, Østrig, 5020
- Rekruttering
- LKH - Universitätsklinikum der PMU Salzburg
-
Vienna, Østrig, 1090
- Rekruttering
- Medical University Vienna
-
Vienna, Østrig, 1020
- Rekruttering
- Krankenhaus der Barmherzigen Brüder
-
Wels, Østrig, 4600
- Rekruttering
- Klinikum Wels Grieskirchen
-
Wiener Neustadt, Østrig, 2700
- Rekruttering
- Universitatsklinikum Wiener Neustadt
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion criteria:
-
Has CD or fistulizing Crohn's Disease (CD) of at least 12 weeks' duration, with colitis, ileitis, or ileocolitis, confirmed at some time in the past by radiography, histology, and/or endoscopy
-
Have moderately to severely active CD, defined as baseline Crohn's Disease Activity Index (CDAI) score greater than or equal to (>=) 220 but less than or equal to (<=) 450
-
Baseline endoscopic evidence of active ileal and/or colonic CD as assessed by central endoscopy reading at the screening endoscopy defined as a screening Simple Endoscopic Score for Crohn's Disease (SES CD) >= 4 (for participants with isolated ileal disease) or >= 6 (for participants with colonic or ileocolonic disease), based on the presence of ulceration in any 1 of the 5 ileocolonic segments, resulting in the following specified ulceration component scores:
- a minimum score of 1 for the component of "size of ulcers" AND
- a minimum score of 1 for the component of "ulcerated surface"
-
In the opinion of the investigator, participant's disease is appropriate to treat with the maintenance dosing regimens utilized in the study
-
Adhere to the requirements for concomitant medications for the treatment of CD as mentioned in the protocol
Exclusion criteria
- Has complications of CD such as symptomatic strictures or stenoses, short gut syndrome, active draining stoma or significant fistulizing disease or any other manifestation anticipated to require surgery within the next year, could preclude the use of the CDAI to assess response to therapy, or would possibly confound the ability to assess the effect of treatment with guselkumab or risankizumab
- Currently has or is suspected to have an abscess
- Has an active fistula during screening or at Week 0 with an anticipated need for surgery
- Has had any kind of bowel resection within 24 weeks, or any other intra-abdominal or other major surgery within 12 weeks, before first dose of study intervention
- Currently has a malignancy or has a history of malignancy within 5 years before screening
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Eksperimentel: Guselkumab
Participants will receive guselkumab induction dose subcutaneously (SC) at Weeks 0, 4, and 8 followed by guselkumab maintenance dose SC once every 4 weeks (q4w) from Week 12 through Week 52. |
Guselkumab will be administered.
Andre navne:
|
|
Eksperimentel: Risankizumab
Participants will receive risankizumab induction dose intravenously (IV) at Weeks 0, 4, and 8 followed by risankizumab maintenance dose SC once every 8 weeks (q8w) from Week 12 through Week 52. |
Risankizumab will be administered. |
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Number of Participants with Deep Remission at Week 52
Tidsramme: At Week 52
|
Deep remission is a composite endpoint defined as achieving both clinical remission and endoscopic remission at the participant level. Clinical remission is defined as Crohn's Disease Activity Index (CDAI) score less than (<) 150-point. CDAI will be assessed by collecting information on 8 different CD-related variables: extra-intestinal manifestations, abdominal mass, weight, hematocrit, total number of liquid stools, abdominal pain/cramping, use of antidiarrheal drug(s), and/or opiates, and general well-being. In general, CDAI score ranges from 0 to approximately 600. Higher score indicates higher disease activity. Endoscopic remission is defined as Simple Endoscopic Score for Crohn's Disease (SES-CD) less than or equal to (<=) 4 with at least a 2-point reduction from baseline and no sub score greater than (>) 1 in any individual component and score can range from 0 to 56. Higher scores indicating severe disease. |
At Week 52
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Composite Endpoint of Number of Participants with Clinical Remission and Endoscopic Response at Week 52
Tidsramme: At Week 52
|
Clinical remission is defined as CDAI score < 150-point. CDAI will be assessed by collecting information on 8 different CD-related variables: extra-intestinal manifestations, abdominal mass, weight, hematocrit, total number of liquid stools, abdominal pain/cramping, use of antidiarrheal drug(s), and/or opiates, and general well-being. In general, CDAI score ranges from 0 to approximately 600. Higher score indicates higher disease activity. Endoscopic response is defined as >50 percent (%) improvement from baseline in the SES CD or SES-CD score <= 2 or a decrease of at least 2 points in participants with a baseline score of 4 and isolated ileal disease. This is a composite endpoint defined to measure achievement of both clinical remission and endoscopic response. |
At Week 52
|
|
Number of Participants with Endoscopic Remission at Week 52
Tidsramme: At Week 52
|
Endoscopic remission is defined as SES-CD <= 4 with at least a 2-point reduction from baseline and no sub score > 1 in any individual component and score can range from 0 to 56. Higher scores indicating severe disease. |
At Week 52
|
|
Number of Participants with Clinical Remission at Week 52
Tidsramme: At Week 52
|
Clinical remission is defined as CDAI score < 150-point. CDAI will be assessed by collecting information on 8 different CD-related variables: extra-intestinal manifestations, abdominal mass, weight, hematocrit, total number of liquid stools, abdominal pain/cramping, use of antidiarrheal drug(s), and/or opiates, and general well-being. In general, CDAI score ranges from 0 to approximately 600. Higher score indicates higher disease activity. |
At Week 52
|
|
Number of Participants with Steroid-Free Clinical Remission at Week 52
Tidsramme: At Week 52
|
Steroid-free clinical remission is defined as clinical remission at Week 52 and not receiving corticosteroids for at least 90 days prior to Week 52. Clinical remission is defined as CDAI score < 150-point. |
At Week 52
|
|
Number of Participants with Abnormalities in Laboratory Parameters
Tidsramme: Up to Week 148
|
Number of participants with abnormalities in laboratory parameters (hematology and chemistry) will be reported. |
Up to Week 148
|
|
Number of Participants With Change From Baseline in Laboratory Abnormalities
Tidsramme: Up to week 148
|
Number of participants with change from baseline in laboratory abnormalities (hematology and chemistry) will be reported. |
Up to week 148
|
|
Number of Participants with Adverse Events (AEs), Serious AEs and AEs Leading to Discontinuation of Study Intervention
Tidsramme: Up to Week 165
|
An AE is any untoward medical occurrence in a participant administered a pharmaceutical (investigational or non investigational) product. An AE does not necessarily have a causal relationship with the treatment. An SAE is any untoward medical occurrence that at any dose results in death, is life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, is a suspected transmission of any infectious agent via a medicinal product and is medically important. |
Up to Week 165
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Efterforskere
Efterforskere
- Studieleder: Janssen Research & Development, LLC Clinical Trial, Janssen Research & Development, LLC
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- CNTO1959CRD3009
- CNTO1959CRD3009 (Anden identifikator: Janssen Research & Development, LLC)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
The data sharing policy of Johnson & Johnson Innovative Medicine is available at www.innovativemedicine.jnj.com/our-innovation/clinical-trials/transparency. As noted on this site, requests for access to the study data can be submitted through Yale Open Data Access (YODA) Project site at yoda.yale.edu.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .